Skip to main content
logo
Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
12.79
+0.19 (1.55%)
May 6, 2026, 10:30 AM EDT - Market open

Phathom Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
1,0161,185556529465600
Market Cap Growth
274.07%112.96%5.12%13.75%-22.47%-36.65%
Enterprise Value
1,3671,266460.51286.18406.26507.75
Last Close Price
12.7916.598.129.1311.2219.67
PE Ratio
--5.48-1.53-2.32-2.22-5.06
PS Ratio
4.886.7710.07776.05--
PB Ratio
--2.70-2.19-7.27-6.228.32
P/TBV Ratio
-2.86-2.76-2.02-6.44-5.8710.09
P/FCF Ratio
--7.09-2.08-3.80-3.15-4.03
P/OCF Ratio
--7.10-2.09-3.85-3.18-4.04
EV/Sales Ratio
6.677.238.33419.62--
EV/EBITDA Ratio
--7.94-1.66-1.72-2.36-3.77
EV/EBIT Ratio
--7.91-1.66-1.71-2.36-3.76
EV/FCF Ratio
--7.58-1.73-2.06-2.75-3.41
Debt / Equity Ratio
-0.49-0.48-0.79-1.90-1.291.26
Debt / EBITDA Ratio
-1.73-1.33-0.73-0.83-0.56-0.68
Debt / FCF Ratio
-1.70-1.27-0.76-1.00-0.66-0.61
Net Debt / Equity Ratio
0.04-0.190.383.330.78-1.27
Net Debt / EBITDA Ratio
0.15-0.510.351.450.340.68
Net Debt / FCF Ratio
0.15-0.490.361.740.400.62
Asset Turnover
0.730.550.140.0000
Inventory Turnover
5.135.183.610.28--
Quick Ratio
2.091.583.929.885.929.69
Current Ratio
2.211.734.2010.256.129.86
Return on Equity (ROE)
40.59%63.97%204.90%273.21%14877.60%-108.01%
Return on Assets (ROA)
-34.24%-50.19%-70.05%-57.83%-97.36%-55.76%
Return on Invested Capital (ROIC)
-295.47%-664.74%-3243.33%2292.10%1215.82%516.12%
Return on Capital Employed (ROCE)
-62.89%-76.24%-83.12%-65.15%-111.58%-65.88%
Earnings Yield
-15.72%-18.26%-65.15%-43.04%-45.01%-19.78%
FCF Yield
-9.77%-14.10%-47.97%-26.30%-31.72%-24.79%
Buyback Yield / Dilution
-13.31%-15.42%-23.18%-31.11%-5.72%-11.36%
Total Shareholder Return
-13.31%-15.42%-23.18%-31.11%-5.72%-11.36%
Updated Apr 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q